# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 10, "J Glaucoma", "", "<http://ctro/data#Publication_26724> <http://ctro/data#hasTitle> \"J Glaucoma\". <http://ctro/data#Publication_26724> <http://ctro/data#hasJournal> \"J Glaucoma\"."
1, PublicationYear, 13, 17, "2000", "", "<http://ctro/data#Publication_26724> <http://ctro/data#hasPublicationYear> \"2000\"."
36936, EndPointDescription, 45, 61, "Clinical success", "", 
0, Title, 45, 211, "Clinical success and quality of life with brimonidine 0 . 2 % or timolol 0 . 5 % used twice daily in glaucoma or ocular t hypertension : a randomized clinical trial .", "", "<http://ctro/data#Publication_26724> <http://ctro/data#hasTitle> \"Clinical success and quality of life with brimonidine 0 . 2 % or timolol 0 . 5 % used twice daily in glaucoma or ocular t hypertension : a randomized clinical trial .\". <http://ctro/data#Publication_26724> <http://ctro/data#hasJournal> \"Clinical success and quality of life with brimonidine 0 . 2 % or timolol 0 . 5 % used twice daily in glaucoma or ocular t hypertension : a randomized clinical trial .\"."
36935, EndPointDescription, 66, 81, "quality of life", "", 
64, Brimonidine, 87, 98, "brimonidine", "", 
69, DoseValue, 99, 104, "0 . 2", "", 
71, Percentage, 105, 106, "%", "", 
65, Timolol, 110, 117, "timolol", "", 
70, DoseValue, 118, 123, "0 . 5", "", 
72, Percentage, 124, 125, "%", "", 
73, Frequency, 131, 142, "twice daily", "", 
66, Glaucoma, 146, 154, "glaucoma", "", "<http://ctro/data#Glaucoma_26741> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glaucoma>. <http://ctro/data#ClinicalTrial_26732> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Glaucoma_26741>."
67, OcularHypertension, 158, 179, "ocular t hypertension", "", "<http://ctro/data#ClinicalTrial_26732> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
68, Randomized, 184, 194, "randomized", "", "<http://ctro/data#ClinicalTrial_26732> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
20562, Brimonidine, 212, 223, "Brimonidine", "", 
3, Author, 249, 258, "Javitt JC", "", "<http://ctro/data#Publication_26724> <http://ctro/data#hasAuthor> \"Javitt JC\"."
4, Author, 267, 279, "Schiffman RM", "", "<http://ctro/data#Publication_26724> <http://ctro/data#hasAuthor> \"Schiffman RM\"."
61, USA, 396, 399, "USA", "", "<http://ctro/data#Population_26753> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
5, ObjectiveDescription, 412, 576, "To compare the clinical success rates and quality of life impact of brimonidine 0 . 2 % with timolol 0 . 5 % in newly diagnosed patients naive to glaucoma therapy .", "", "<http://ctro/data#ClinicalTrial_26732> <http://ctro/data#hasObjectiveDescription> \"To compare the clinical success rates and quality of life impact of brimonidine 0 . 2 % with timolol 0 . 5 % in newly diagnosed patients naive to glaucoma therapy .\"."
36937, EndPointDescription, 427, 443, "clinical success", "", "<http://ctro/data#EndPointDescription_26762> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_26761> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_26762>."
36938, EndPointDescription, 454, 469, "quality of life", "", "<http://ctro/data#EndPointDescription_26767> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_26766> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_26767>."
27, Brimonidine, 480, 491, "brimonidine", "", 
28, DoseValue, 492, 497, "0 . 2", "", 
29, Percentage, 498, 499, "%", "", 
30, Timolol, 505, 512, "timolol", "", 
31, DoseValue, 513, 518, "0 . 5", "", 
32, Percentage, 519, 520, "%", "", 
33, Precondition, 524, 574, "newly diagnosed patients naive to glaucoma therapy", "", "<http://ctro/data#Population_26753> <http://ctro/data#hasPrecondition> \"newly diagnosed patients naive to glaucoma therapy\"."
20563, Glaucoma, 558, 566, "glaucoma", "", 
36934, Prospective, 589, 600, "prospective", "", "<http://ctro/data#ClinicalTrial_26732> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
7, Multicenter, 603, 614, "multicenter", "", "<http://ctro/data#ClinicalTrial_26732> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
8, Randomized, 617, 627, "randomized", "", 
9, DoubleBlind, 630, 645, "double - masked", "", 
10, Frequency, 711, 722, "twice daily", "", "<http://ctro/data#Intervention_26819> <http://ctro/data#hasFrequency> \"twice daily\". <http://ctro/data#Intervention_26825> <http://ctro/data#hasFrequency> \"twice daily\"."
11, Brimonidine, 723, 743, "brimonidine tartrate", "", "<http://ctro/data#Medication_26838> <http://ctro/data#hasDrug> <http://ctro/data#Brimonidine>."
12, DoseValue, 744, 749, "0 . 2", "", "<http://ctro/data#Medication_26838> <http://ctro/data#hasDoseValue> \"0 . 2\"."
13, Percentage, 750, 751, "%", "", "<http://ctro/data#Medication_26838> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
14, Timolol, 780, 795, "timolol maleate", "", "<http://ctro/data#Medication_26831> <http://ctro/data#hasDrug> <http://ctro/data#Timolol>."
15, DoseValue, 796, 801, "0 . 5", "", 
16, Percentage, 802, 803, "%", "", "<http://ctro/data#Medication_26831> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
17, Glaucoma, 821, 829, "glaucoma", "", 
18, OcularHypertension, 836, 855, "ocular hypertension", "", 
19, NumberPatientsCT, 872, 892, "Two hundred nineteen", "", 
20, NumberPatientsArm, 920, 923, "111", "", 
22, Brimonidine, 931, 942, "brimonidine", "", 
21, NumberPatientsArm, 953, 956, "108", "", 
23, Timolol, 964, 971, "timolol", "", 
24, Frequency, 1023, 1034, "twice daily", "", 
25, Duration, 1039, 1047, "4 months", "", "<http://ctro/data#ClinicalTrial_26732> <http://ctro/data#hasCTduration> \"4 months\"."
36939, EndPointDescription, 1074, 1090, "clinical success", "", 
25351, IOP, 1109, 1129, "intraocular pressure", "", 
25352, IOP, 1132, 1135, "IOP", "", 
20572, EndPointDescription, 1170, 1185, "Quality of life", "", 
109, MeasurementDevice, 1217, 1283, "SF - 36 Health Survey and Glaucoma Disability Index questionnaires", "", 
60, EndPointDescription, 1296, 1312, "Clinical success", "", 
135, PercentageAffected, 1317, 1319, "71", "", "<http://ctro/data#Outcome_26872> <http://ctro/data#hasPercentageAffected> \"71\"."
137, NumberAffected, 1324, 1326, "75", "", "<http://ctro/data#Outcome_26872> <http://ctro/data#hasNumberAffected> \"75\"."
110, FinalNumPatientsArm, 1329, 1332, "106", "", "<http://ctro/data#Arm_26810> <http://ctro/data#hasFinalNumPatientsArm> \"106\"."
36, Brimonidine, 1340, 1351, "brimonidine", "", 
136, PercentageAffected, 1356, 1358, "70", "", "<http://ctro/data#Outcome_26845> <http://ctro/data#hasPercentageAffected> \"70\"."
138, NumberAffected, 1363, 1365, "73", "", "<http://ctro/data#Outcome_26845> <http://ctro/data#hasNumberAffected> \"73\"."
111, FinalNumPatientsArm, 1368, 1371, "105", "", "<http://ctro/data#Arm_26801> <http://ctro/data#hasFinalNumPatientsArm> \"105\"."
37, Timolol, 1379, 1386, "timolol", "", 
38, Mean, 1422, 1426, "mean", "", 
39, IOP, 1439, 1442, "IOP", "", "<http://ctro/data#IOP_26772> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_26771> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_26772>."
116, Reduction, 1447, 1452, "6 . 5", "", "<http://ctro/data#Outcome_26899> <http://ctro/data#hasChangeValue> \"6 . 5\"."
41, mmHg, 1453, 1458, "mm Hg", "", "<http://ctro/data#Endpoint_26771> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
42, Brimonidine, 1464, 1475, "brimonidine", "", 
117, Reduction, 1480, 1485, "6 . 2", "", "<http://ctro/data#Outcome_26926> <http://ctro/data#hasChangeValue> \"6 . 2\"."
44, mmHg, 1486, 1491, "mm Hg", "", 
45, Timolol, 1497, 1504, "timolol", "", 
92910, ObservedResult, 1584, 1635, "slightly higher rate of ocular burning and stinging", "", 
20565, EndPointDescription, 1608, 1622, "ocular burning", "", "<http://ctro/data#EndPointDescription_26782> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_26781> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_26782>."
20564, Smarting, 1627, 1635, "stinging", "", "<http://ctro/data#Endpoint_26786> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Smarting>."
46, Brimonidine, 1643, 1654, "brimonidine", "", 
92908, ObservedResult, 1719, 1777, "No significant chronotropic effects on the heart were seen", "", "<http://ctro/data#Outcome_27007> <http://ctro/data#hasObservedResult> \"No significant chronotropic effects on the heart were seen\"."
20567, EndPointDescription, 1734, 1767, "chronotropic effects on the heart", "", "<http://ctro/data#EndPointDescription_26792> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_26791> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_26792>."
47, Brimonidine, 1783, 1794, "brimonidine", "", 
92909, ObservedResult, 1803, 1881, "small but significant mean decreases in heart rate were seen at months 1 and 4", "", "<http://ctro/data#Outcome_27034> <http://ctro/data#hasObservedResult> \"small but significant mean decreases in heart rate were seen at months 1 and 4\"."
126, Mean, 1825, 1829, "mean", "", "<http://ctro/data#Mean_26798> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_26796> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_26798>."
20569, HeartRate, 1843, 1853, "heart rate", "", "<http://ctro/data#HeartRate_26797> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#HeartRate>. <http://ctro/data#Endpoint_26796> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HeartRate_26797>."
123, TimePoint, 1867, 1875, "months 1", "", 
124, TimePoint, 1880, 1881, "4", "", 
48, Timolol, 1887, 1894, "timolol", "", 
20570, ObservedResult, 1984, 2067, "Quality of life remained stable , with no significant between - group differences .", "", "<http://ctro/data#Outcome_27061> <http://ctro/data#hasObservedResult> \"Quality of life remained stable , with no significant between - group differences .\"."
20571, EndPointDescription, 1984, 1999, "Quality of life", "", 
49, ConclusionComment, 2082, 2273, "As a first - line agent for the treatment of glaucoma and ocular hypertension , brimonidine has clinical effectiveness equivalent to timolol , but with less chronotropic effect on the heart .", "", "<http://ctro/data#ClinicalTrial_26732> <http://ctro/data#hasConclusionComment> \"As a first - line agent for the treatment of glaucoma and ocular hypertension , brimonidine has clinical effectiveness equivalent to timolol , but with less chronotropic effect on the heart .\"."
50, Glaucoma, 2127, 2135, "glaucoma", "", 
51, OcularHypertension, 2140, 2159, "ocular hypertension", "", 
52, Brimonidine, 2162, 2173, "brimonidine", "", 
53, Timolol, 2215, 2222, "timolol", "", 
54, ConclusionComment, 2274, 2383, "Brimonidine is a viable alternative to timolol for first - line therapy in glaucoma and ocular hypertension .", "", 
55, Brimonidine, 2274, 2285, "Brimonidine", "", 
56, Timolol, 2313, 2320, "timolol", "", 
57, Glaucoma, 2349, 2357, "glaucoma", "", 
58, OcularHypertension, 2362, 2381, "ocular hypertension", "", 
59, PMID, 2391, 2399, "10877373", "", "<http://ctro/data#Publication_26724> <http://ctro/data#hasPMID> \"10877373\"."
